Bcr-Abl expression in either T-ALL or B-ALL cells triggers an IKK-dependent activation of NF-κB that is crucial to the pathogenicity of Philadelphia positive (Ph+) leukemias [25]. This evidence concerns the gene NFKB1 and leukemia.